blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2069346

EP2069346 - ACETAMIDE AND CARBOXAMIDE DERIVATIVES OF AZAADAMANTANE AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.10.2012
Database last updated on 03.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, IL 60064-3500 / US
[N/P]
Former [2009/25]For all designated states
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, IL 60064 / US
Inventor(s)01 / SCANIO, Marc J., C.
2907 Harvest Lane
Lindenhurst, Illinois 60046 / US
02 / SHI, Lei
700 Creekside Circle
Gurnee, Illinois 60031 / US
03 / BUNNELLE, William, H.
1826 Victoria Road
Mundelein, Illinois 60060 / US
04 / SCHRIMPF, Michael, R.
327 Cambridge Drive
Grayslake, Illinois 60030 / US
 [2009/25]
Representative(s)Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd
Thierschstrasse 11
80538 München / DE
[N/P]
Former [2009/36]Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11
80538 München / DE
Former [2009/25]Modiano, Micaela Nadia, et al
Modiano Josif Pisanty & Staub Ltd Thierschstrasse 11
80538 München / DE
Application number, filing date08732554.420.03.2008
[2009/25]
WO2008US57643
Priority number, dateUS20070896749P23.03.2007         Original published format: US 896749 P
[2009/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008118743
Date:02.10.2008
Language:EN
[2008/40]
Type: A1 Application with search report 
No.:EP2069346
Date:17.06.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 02.10.2008 takes the place of the publication of the European patent application.
[2009/25]
Type: B1 Patent specification 
No.:EP2069346
Date:21.12.2011
Language:EN
[2011/51]
Search report(s)International search report - published on:KR02.10.2008
(Supplementary) European search report - dispatched on:EP31.07.2009
ClassificationIPC:C07D471/18, A61K31/439, A61P25/00
[2009/36]
CPC:
C07D471/18 (EP,US); A61P21/02 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/28 (EP); A61P25/34 (EP);
A61P29/00 (EP); A61P43/00 (EP) (-)
Former IPC [2009/25]C07D471/18
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/25]
Extension statesAL18.03.2009
BA18.03.2009
MK18.03.2009
RS18.03.2009
TitleGerman:ACETAMID- UND CARBOXAMID-DERIVATE VON AZAADAMANTAN SOWIE VERFAHREN ZU IHRER VERWENDUNG[2009/25]
English:ACETAMIDE AND CARBOXAMIDE DERIVATIVES OF AZAADAMANTANE AND METHODS OF USE THEREOF[2009/25]
French:DÉRIVÉS ACÉTAMIDE ET CARBOXAMIDE D'AZAADAMANTANE ET LEURS PROCÉDÉS D'UTILISATION[2009/25]
Entry into regional phase18.03.2009National basic fee paid 
18.03.2009Search fee paid 
18.03.2009Designation fee(s) paid 
18.03.2009Examination fee paid 
Examination procedure18.03.2009Amendment by applicant (claims and/or description)
18.03.2009Examination requested  [2009/25]
28.10.2009Despatch of a communication from the examining division (Time limit: M06)
20.04.2010Reply to a communication from the examining division
25.05.2011Communication of intention to grant the patent
29.09.2011Fee for grant paid
29.09.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.10.2009
Opposition(s)24.09.2012No opposition filed within time limit [2012/48]
Fees paidRenewal fee
08.03.2010Renewal fee patent year 03
10.03.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.03.2008
AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
FI21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
MT21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
TR21.12.2011
IE20.03.2012
LU20.03.2012
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
[2014/34]
Former [2014/27]AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
FI21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
MT21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
TR21.12.2011
IE20.03.2012
LU20.03.2012
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2014/21]AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
FI21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
MT21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
TR21.12.2011
IE20.03.2012
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2013/35]AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
FI21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
MT21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
IE20.03.2012
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2013/29]AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
FI21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
IE20.03.2012
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2013/08]AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
IE20.03.2012
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2013/07]AT21.12.2011
BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
NO21.03.2012
GR22.03.2012
CH31.03.2012
LI31.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2012/49]BE21.12.2011
CY21.12.2011
CZ21.12.2011
DK21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
NO21.03.2012
GR22.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2012/47]BE21.12.2011
CY21.12.2011
CZ21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
NO21.03.2012
GR22.03.2012
MC31.03.2012
IS21.04.2012
PT23.04.2012
Former [2012/37]BE21.12.2011
CY21.12.2011
CZ21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
PL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
NO21.03.2012
GR22.03.2012
IS21.04.2012
PT23.04.2012
Former [2012/36]BE21.12.2011
CY21.12.2011
CZ21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
RO21.12.2011
SE21.12.2011
SI21.12.2011
SK21.12.2011
BG21.03.2012
NO21.03.2012
GR22.03.2012
IS21.04.2012
Former [2012/35]BE21.12.2011
CY21.12.2011
CZ21.12.2011
EE21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
SE21.12.2011
SI21.12.2011
BG21.03.2012
NO21.03.2012
GR22.03.2012
IS21.04.2012
Former [2012/34]BE21.12.2011
CY21.12.2011
CZ21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
SE21.12.2011
SI21.12.2011
NO21.03.2012
GR22.03.2012
IS21.04.2012
Former [2012/30]BE21.12.2011
CY21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
SE21.12.2011
SI21.12.2011
NO21.03.2012
GR22.03.2012
Former [2012/28]CY21.12.2011
HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
SE21.12.2011
SI21.12.2011
NO21.03.2012
GR22.03.2012
Former [2012/27]HR21.12.2011
LT21.12.2011
LV21.12.2011
NL21.12.2011
SE21.12.2011
SI21.12.2011
NO21.03.2012
GR22.03.2012
Former [2012/24]LT21.12.2011
LV21.12.2011
NL21.12.2011
SE21.12.2011
SI21.12.2011
NO21.03.2012
GR22.03.2012
Former [2012/20]LT21.12.2011
NO21.03.2012
Documents cited:Search[A]WO9402482  (SEARLE & CO [US], et al) [A] 1-13 * the whole document *;
 [A]  - IRIEPA I ET AL, "Synthesis and structural study of a series of amides derived from 4alpha- and 4beta-amino-1-azaadamantanes as potential 5-HT3 receptor antagonists", JOURNAL OF MOLECULAR STRUCTURE, ELSEVIER, AMSTERDAM, NL, (19990101), vol. 509, ISSN 0022-2860, pages 105 - 114, XP002414060 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0022-2860(99)00214-8
International search[A]WO9402482  (SEARLE & CO [US], et al) [A] 1-8, 12-13* See the whole document. *;
 [A]WO9951601  (REYNOLDS TOBACCO CO R [US], et al) [A] 1-8, 12-13 * See the whole document. *;
 [A]WO9951602  (REYNOLDS TOBACCO CO R [US], et al) [A] 1-8, 12-13 * See the whole document. *;
 [A]WO0011001  (UCB SA [BE], et al) [A] 1-8, 12-13 * See the whole document. *;
 [A]  - PASMAN, P. et al., "Chromophoric systems based upon through-bond interaction IV.", Tetrahedron, (19760000), vol. 32, no. 22, ISSN 0040-4020, pages 2827 - 2830, XP008104172 [A] 1-8, 12-13 * . See the whole document. *

DOI:   http://dx.doi.org/10.1016/0040-4020(76)80130-5
by applicantUS4816453
 WO9215593
 US5260303
 WO9400454
 US5280028
 US5399562
 US5434151
 US5591749
 US5604239
    - VINCLER, M.; MCINTOSH, J. M., "Targeting the ?9?10 nicotinic acetylcholine receptor to treat severe pain", EXP. OPIN. THER. TARGETS, (2007), vol. 11, no. 7, doi:doi:10.1517/14728222.11.7.891, pages 891 - 897, XP009159252

DOI:   http://dx.doi.org/10.1517/14728222.11.7.891
    - IRIEPA, I ET AL., J. MOLEC. STRUCT, (1999), vol. 509, page 105
    - FLYNN, D. L. ET AL., BIOORG. MED. CHEM. LETT., (1992), vol. 2, page 1613
    - LEVIN, E.D., J. NEUROBIOL., (2002), vol. 53, pages 633 - 640
    - JONNALA, R. B.; BUCCAFUSCO, J. J., J. NEUROSCI. RES., (2001), vol. 66, pages 565 - 572
    - SHIMOHAMA, S. ET AL., BRAIN RES., (1998), vol. 779, pages 359 - 363
    - BECKER, D. P.; FLYNN, D. L., SYNTHESIS, (1992), pages 1080 - 1082
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.